{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:54Z","timestamp":1787021934257,"version":"build-2736575974"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109148","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T13:54:11Z","timestamp":1412690051000},"page":"e109148","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings"],"prefix":"10.1371","volume":"9","author":[{"given":"Andrew","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cambiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travor","family":"Magubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Revill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"ref1","unstructured":"WHO (2013) Global update on HIV treatment 2013: Results, impact and opportunities."},{"key":"ref2","unstructured":"WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/590943","article-title":"Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials","volume":"47","author":"R Gupta","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/infdis\/jit411","article-title":"Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch","volume":"209","author":"V Johnston","year":"2014","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01029.x","article-title":"British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012","volume":"13","author":"I Williams","year":"2012","journal-title":"HIV Med"},{"key":"ref6","unstructured":"US Department of Health and Human Services (2013) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"d6792","DOI":"10.1136\/bmj.d6792","article-title":"Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial","volume":"343","author":"J Mermin","year":"2011","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"d6884","DOI":"10.1136\/bmj.d6884","article-title":"CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study","volume":"343","author":"JG Kahn","year":"2011","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1001494","DOI":"10.1371\/journal.pmed.1001494","article-title":"Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand","volume":"10","author":"G Jourdain","year":"2013","journal-title":"PLoS Med"},{"key":"ref10","unstructured":"Saag MS, Westfall A, Luhanga D (2012) A cluster randomized trial of routine vs discretionary viral load monitoring among adults starting ART: Zambia. Session 24."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1473-3099(11)70168-2","article-title":"Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110\/ESTHER): a randomised non-inferiority trial","volume":"11","author":"C Laurent","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1473-3099(13)70073-2","article-title":"Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110\/ESTHER): a cost-effectiveness analysis","volume":"13","author":"S Boyer","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(08)60624-8","article-title":"Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model","volume":"371","author":"AN Phillips","year":"2008","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3181d0db97","article-title":"Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness","volume":"54","author":"AD Kimmel","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/QAD.0b013e3283560678","article-title":"Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis","volume":"26","author":"RL Hamers","year":"2012","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/QAD.0b013e328344037a","article-title":"Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings","volume":"25","author":"AN Phillips","year":"2011","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0b013e3283536988","article-title":"Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis","volume":"26","author":"J Estill","year":"2012","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e57611","DOI":"10.1371\/journal.pone.0057611","article-title":"Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study","volume":"8","author":"J Estill","year":"2013","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1758-2652-14-38","article-title":"Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?","volume":"14","author":"RS Braithwaite","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2214-109X(13)70048-2","article-title":"Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models","volume":"2","author":"D Keebler","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref21","unstructured":"M\u00e9decins Sans Fronti\u00e8res (2013) Untangling the web of antiretroviral price reductions. 16th Edition."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1758-2652-14-24","article-title":"The net cost of incorporating resistance testing into HIV\/AIDS treatment in South Africa: a Markov model with primary data","volume":"14","author":"S Rosen","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/cid\/cis887","article-title":"The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa","volume":"56","author":"JH Levison","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jit111","article-title":"Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings","volume":"207","author":"V Cambiano","year":"2013","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/QAD.0000000000000082","article-title":"Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation","volume":"28","author":"V Cambiano","year":"2014","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ije\/dyq055","article-title":"HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review","volume":"39","author":"S Gregson","year":"2010","journal-title":"Int J Epidemiol"},{"key":"ref27","unstructured":"UNAIDS (2012) Global AIDS response progress report 2012. Follow up to the 2011 Political Declaration on HIV\/AIDS: Intensifying our efforts to eliminate HIV\/AIDS. Zimbabwe Country Report. Reporting Period: January 2010\u2013December 2011."},{"key":"ref28","unstructured":"Zimbabwe National Statistics Agency and ICF International, Inc (2012) Zimbabwe Demographic and Health Survey 2010\u20132011."},{"key":"ref29","unstructured":"Mabugu T (2013) Personal communication."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/QAD.0b013e32830e4cf3","article-title":"Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study","volume":"22","author":"KJ Lee","year":"2008","journal-title":"AIDS"},{"key":"ref31","unstructured":"Claxton K, Walker S, Palmer S, Sculpher M (2010) Appropriate Perspectives for Health Care Decisions. Centre for Health Economics Research Paper 54. Centre for Health Economics, University of York 54."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"JA Salomon","year":"2012","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e77691","DOI":"10.1371\/journal.pone.0077691","article-title":"Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study","volume":"8","author":"W von","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/651684","article-title":"Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy","volume":"50","author":"A Cozzi-Lepri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QAD.0b013e32831c54e5","article-title":"HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review","volume":"23","author":"WF Bierman","year":"2009","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e328011ec53","article-title":"HIV drug resistance surveillance for prioritizing treatment in resource-limited settings","volume":"21","author":"RP Walensky","year":"2007","journal-title":"AIDS"},{"key":"ref37","unstructured":"Chung M (2014) Personal Communication."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/QAI.0b013e318266ee3f","article-title":"Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program","volume":"61","author":"V Johnston","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref39","unstructured":"WHO (2012) WHO HIV Drug Resistance Report 2012."}],"updated-by":[{"DOI":"10.1371\/journal.pone.0115079","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:27:42Z","timestamp":1589009262000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109148"}},"subtitle":[],"editor":[{"given":"David W.","family":"Dowdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109148","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719990591.793500886","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]}}}